AstraZeneca Option Alert: Jan 16 $80 Calls at the Bid: 2000 vs 8152 OI

AstraZeneca Option Alert: Jan 16 $80 Calls at the Bid: 2000 @ $5.8 vs 8152 OI; Ref=$80.72

AstraZeneca Option Alert: Jan 16 $80 Calls at the Bid: 2000 vs 8511 OI

AstraZeneca Option Alert: Jan 16 $80 Calls at the Bid: 2000 @ $5.9 vs 8511 OI; Ref=$80.705

AstraZeneca

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Possible Reversal

News

Markets

AMGN

Nuovi dazi in arrivo? Il mercato azionario reagisce con cali significativi sui principali produttori di farmaci.

Trump fa crollare anche i titoli farmaceutici: ecco cosa ha detto stavolta

Il colosso farmaceutico lancia la sfida ai farmaci più gettonati contro l&#39;obesità con un nuovo trattamento: ecco cosa rivelano gli studi.

È questo il miglior prodotto per perdere peso? Amgen sfida Ozempic e Zepbound

Specialty ETFs

ETFs

DBEF

NOVO

Crescita inattesa nel vecchio continente: quali strumenti finanziari offrono la migliore esposizione al mercato e minimizzano i rischi?

I grandi fondi puntano sull&#39;Europa, devi farlo anche tu? 3 ETF da tenere d&#39;occhio

AstraZeneca PLC - American Depositary Shares

AstraZeneca PLC

Precidian ETFs Trust AstraZeneca PLC ADRhedged

AZN Capital Corp

Press Releases

Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension

ENHERTU® Plus Pertuzumab Granted Breakthrough Therapy Designation in the U.S. as First-Line Therapy for Patients with HER2 Positive Metastatic Breast Cancer

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D

IMFINZI® (durvalumab) granted Priority Review and Breakthrough Therapy Designation in the US for patients with resectable early-stage gastric and gastroesophageal junction cancers

AstraZeneca results: H1 and Q2 2025

Contracts

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) and adults with generalized myasthenia gravis (gMG)

The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact

FLUMIST (Influenza, Vaccine Live, Intranasal), the nation's only nasal spray flu vaccine, now available for home delivery

SOPH

TYO:4568

Axsome Therapeutics

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Perrigo

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda Pharmaceutical Co

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Indus

Verona Pharma plc - American Depositary Shares

Verona Pharma

Viatris

Zoetis

TD Cowen

Argus Research

Goldman Sachs

BMO Capital

Morgan Stanley

Screenshot 2024-09-30 at 9.13.36 PM

Biotech

General

TNXP

VRTX

The Rush For Non-Addictive Painkillers To Counter The Opioid Crisis Puts Two Companies Closer To FDA Decisions

Screenshot 2024-09-30 at 5.38.54 PM

Movers & Shakers

COSM

Nestle Sponsored representing Registered Shares Series B

NSRGY

VTRS

How Cosmos Health&#39;s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
11:53 AMAug 21, 2025	CALL	$80.00	Jan 16, 2026	141	2000	2000	25	8152	TRADE	NEUTRAL
11:48 AMAug 20, 2025	CALL	$80.00	Jan 16, 2026	141	5	2000	0	8511	TRADE	BULLISH

Comments

AstraZeneca

Unusual Options Activity for

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO